Metraipolis › archive › dc_0126df8a24bd

Repurposing the phospholipase A2 inhibitor, darapladib, to combat multidrug-resistant fungal pathogens, including Candida auris — Europe PMC PMID:42932329

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42932329
DOI
10.1371/journal.pone.0361366
License (as archived)
solo-consultazione
Archived
2026-10-31T21:21:43.251Z
SHA-256 of the archived text
ff125b64b5fa41e2f83cdc7543c1b16ae49a2e433ef1161294c02351316f343d
Stable URL of this page
https://metraipolis.com/documento/dc_0126df8a24bd

How to cite

Repurposing the phospholipase A2 inhibitor, darapladib, to combat multidrug-resistant fungal pathogens, including Candida auris — Europe PMC PMID:42932329 — Europe PMC (en), https://europepmc.org/article/MED/42932329 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0126df8a24bd (Metraipolis archive dc_0126df8a24bd, sha256 ff125b64b5fa41e2f83cdc7543c1b16ae49a2e433ef1161294c02351316f343d)
BibTeX
@misc{dc0126df8a24bd,
  title = {Repurposing the phospholipase A2 inhibitor, darapladib, to combat multidrug-resistant fungal pathogens, including Candida auris — Europe PMC PMID:42932329},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42932329},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0126df8a24bd; sha256 ff125b64b5fa41e2f83cdc7543c1b16ae49a2e433ef1161294c02351316f343d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42932329. Agents can read the archived copy with the MCP tool read_document.